When OpenAI in October announced “apps in ChatGPT,” allowing people to use external apps like Zillow or Spotify in ...
From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...
Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback